Clinical Study of PM1003 in Phase I/IIa Treatment of Advanced Malignant Solid Tumors

NCT05862831 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

285

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

BIOLOGICAL: PM1003 Injection

Sponsor

Biotheus Inc.